The TRAIL-mediated cytotoxic and apoptotic pathways may be a target of the chemopreventive agents in prostate cancer cells and the overcoming TRAIL-resistance by chalcones may be one of the mechanisms responsible for their cancer preventive effects. Here, TNFSF10 is linked to prostate carcinoma.